Skip to main content

Table 2 Relative expression level of Psoralen group over that Control group

From: Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer

Gene symbol Control Psoralen log2FoldChange P value
KRTAP2-3 473.4431128 77.96785331 −2.602239769 1.55E-31
FOSL1 11296.63679 5566.561955 −1.021034857 3.49E-26
MMP1 1170.248705 212.1662542 −2.463548055 1.18E-13
MYPN 456.4454562 187.019253 −1.287255674 1.63E-10
ENSG00000231826.1 761.8035897 366.7059488 −1.054795416 7.26E-08
ALPP 320.5900834 127.107873 −1.334676407 1.22E-07
ENSG00000237862.1 247.8975043 105.2724733 −1.235615498 1.45E-07
LRRC15 313.4134599 144.8134519 −1.113871516 3.37E-07
TMEM40 398.6759476 196.9516533 −1.017375042 5.19E-07
ALPL 205.4467798 88.21207065 −1.21971673 1.31E-06
TMEM200A 714.8598445 303.7664782 −1.234697743 3.42E-06
LCE2A 455.8712616 224.9098164 −1.019279833 8.62E-06
SIRPB1 43.66423935 9.736212337 −2.165019671 1.03E-05
SESN3 73.33189937 163.1626044 1.153797628 1.94E-05
PEAR1 195.9475924 80.66338615 −1.280481972 2.38E-05
HSD17B6 83.7271271 31.44521183 −1.412854769 3.95E-05
ENSG00000261159.1 17.47612762 1.611337899 −3.439054581 6.33E-05
INHBA 92.57825197 34.35526917 −1.430141936 6.82E-05
ARNT2 115.3737968 50.98582145 −1.17814759 8.87E-05
IGFN1 87.83302938 31.6306287 −1.473441332 1.02E-04
RXFP4 0 10.4296342 Inf 1.26E-04
  1. The table displays the results of the RNA-Seq data comparison before and after psoralen treatment. It holds the description, log2 fold change (FC) of the differentially expressed genes. Positive log2 fold changes indicate higher gene expression after psoralen treatment, while negative log2 fold changes indicate lower gene expression after psoralen treatment